OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SAMN51

Sampre Nutritions Ltd

Food ProcessingVerified

Sampre Nutritions Ltd maintains a debt-to-equity ratio of 0.78, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with a current ratio of 1.31, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) is 2.1%, and its return on assets (ROA) is 1.05%. These figures are below the typical thresholds for strong performance in the food processing industry, indicating that the company is not generating robust returns relative to its equity and asset base. The company's operating income of INR 11.2 million and net income of INR 4.7 million suggest a narrow profit margin, which may be a concern in a competitive industry. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher operational and market risks if demand in its primary market fluctuates. Looking ahead, the company's growth trajectory is uncertain. The available data does not provide specific revenue growth projections for the current or next fiscal year. However, the company's capital expenditure of INR -37.09 million indicates a reduction in investment in new assets, which may signal a conservative approach to growth or a focus on cost management. The company's risk profile includes medium liquidity risk and low dilution risk. The negative net cash position after debt is a key liquidity flag, and while the company has not indicated plans for significant equity dilution, the potential for future dilution remains low. The company's financial structure and operating cash flow of INR 39.52 million suggest it has the capacity to meet its short-term obligations, but long-term debt of INR 175.00 million could pose a challenge if interest rates rise or if cash flow is disrupted. Recent events and filings do not indicate any major corporate actions or strategic shifts. The company's latest financial statements and disclosures do not highlight any significant legal, regulatory, or operational risks that would impact its near-term performance.

30-day price · SAMN-2.36 (-14.0%)
Low$14.28High$19.89Close$14.55As of15 May, 00:00 UTC
Profile
CompanySampre Nutritions Ltd
TickerSAMN.BO
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Sampre Nutritions Ltd maintains a debt-to-equity ratio of 0.78, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with a current ratio of 1.31, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) is 2.1%, and its return on assets (ROA) is 1.05%. These figures are below the typical thresholds for strong performance in the food processing industry, indicating that the company is not generating robust returns relative to its equity and asset base. The company's operating income of INR 11.2 million and net income of INR 4.7 million suggest a narrow profit margin, which may be a concern in a competitive industry. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher operational and market risks if demand in its primary market fluctuates. Looking ahead, the company's growth trajectory is uncertain. The available data does not provide specific revenue growth projections for the current or next fiscal year. However, the company's capital expenditure of INR -37.09 million indicates a reduction in investment in new assets, which may signal a conservative approach to growth or a focus on cost management. The company's risk profile includes medium liquidity risk and low dilution risk. The negative net cash position after debt is a key liquidity flag, and while the company has not indicated plans for significant equity dilution, the potential for future dilution remains low. The company's financial structure and operating cash flow of INR 39.52 million suggest it has the capacity to meet its short-term obligations, but long-term debt of INR 175.00 million could pose a challenge if interest rates rise or if cash flow is disrupted. Recent events and filings do not indicate any major corporate actions or strategic shifts. The company's latest financial statements and disclosures do not highlight any significant legal, regulatory, or operational risks that would impact its near-term performance.
Key takeaways
  • Sampre Nutritions Ltd has a moderate debt-to-equity ratio of 0.78, indicating a balanced capital structure.
  • The company's ROE of 2.1% and ROA of 1.05% are below industry norms, suggesting suboptimal returns on equity and assets.
  • The company's liquidity position is medium, with a current ratio of 1.31 and a negative net cash position after debt.
  • Sampre Nutritions Ltd has not disclosed geographic or segment diversification, which could increase its exposure to market-specific risks.
  • The company's capital expenditure is negative, indicating a reduction in investment, which may affect long-term growth.
  • The company's risk profile is characterized by medium liquidity risk and low dilution risk.
  • --
  • **RATIONALES**:
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$47.6M
Gross profit-$27.8M
Operating income$11.2M
Net income$4.7M
R&D
SG&A
D&A
SBC
Operating cash flow$39.5M
CapEx-$37.1M
Free cash flow
Total assets$447.5M
Total liabilities$222.8M
Total equity$224.7M
Cash & equivalents$2.8M
Long-term debt$175.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$182.3M$31.7M$755.8k-$4.7M
FY-3$231.3M$18.8M$3.1M$6.4M
FY-2$371.1M$22.3M$3.5M-$22.4M
FY-1$251.5M$22.9M$2.3M-$16.4M
FY0$251.2M-$58.3M-$76.7M-$59.8M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$382.9M$107.8M$973.1k
FY-3$377.0M$110.9M$825.0k
FY-2$435.9M$211.6M$1.3M
FY-1$447.5M$224.7M$2.8M
FY0$1.15B$908.8M$2.3M
PeriodOCFCapExFCFSBC
FY-4-$1.8M-$23.6M-$4.7M
FY-3$24.1M-$13.0M$6.4M
FY-2$8.8M-$44.1M-$22.4M
FY-1$39.5M-$37.1M-$16.4M
FY0$843.0k-$2.8M-$59.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$47.6M$11.2M$4.7M
FQ-6$45.1M$5.3M$989.0k
FQ-5$72.7M$5.7M$1.2M
FQ-4$55.8M$0.00-$5.4M
FQ-3$77.7M-$69.3M-$73.5M
FQ-2$108.7M$9.9M$7.1M
FQ-1$100.0M$13.4M$9.0M
FQ0$73.9M$9.8M$6.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$447.5M$224.7M$2.8M
FQ-6
FQ-5$496.0M$270.0M$2.1M
FQ-4
FQ-3$1.15B$908.8M$2.3M
FQ-2
FQ-1$1.21B$979.8M$4.2M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$39.5M-$37.1M
FQ-6
FQ-5$2.2M
FQ-4
FQ-3$843.0k-$2.8M
FQ-2
FQ-1-$6.1M$0.00
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$224.7M
Net cash-$172.2M
Current ratio1.3
Debt/Equity0.8
ROA1.1%
ROE2.1%
Cash conversion8.4%
CapEx/Revenue-77.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 1040 companies
MetricSAMNActivity
Op margin23.5%5.6% medp25 2.1% · p75 11.2%top quartile
Net margin9.9%3.9% medp25 0.5% · p75 8.5%top quartile
Gross margin-58.3%23.3% medp25 14.8% · p75 32.6%bottom quartile
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-77.8%-4.1% medp25 -8.9% · p75 -1.9%bottom quartile
Debt / equity78.0%37.6% medp25 7.2% · p75 84.5%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-02 03:41 UTC#119bbb06
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 07:30 UTCJob: 6b59fbfa